# Femasys Inc: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Femasys Inc](/companies/femy.md) (CIK 1339005)
- Form: 10-K/A
- Filed: 2023-07-24
- Accepted by EDGAR: Jul 21, 2023, 17:40 ET
- Period: 2022-12-31
- Accession: 0001140361-23-035663
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339005/000114036123035663/brhc20056144_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339005/000114036123035663/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | $1.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2022-01-01 to 2022-12-31 | $441.9k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2022-01-01 to 2022-12-31 | $764.3k | us-gaap:GrossProfit |
| Research and development | 12 months, 2022-01-01 to 2022-12-31 | $5.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | −$11.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2022-01-01 to 2022-12-31 | $13.5k | us-gaap:InterestExpense |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | $6.3k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | −$11.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | −$0.96 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | −$0.96 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2022-01-01 to 2022-12-31 | 11,815,019 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | −$10.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $407.5k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-12-31 | $13.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-12-31 | $14.1m | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | $16.9m | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | $1.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-12-31 | $1.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2022-12-31 | $15.2m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1339005/000114036123035663/brhc20056144_10ka.htm

Filed Jul 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-035663. Last ingested by Listed: Nov 5, 2026, 21:32 ET. No prices; not investment advice.